- Research Article
- Open Access
Several strains, one disease: experimental investigation of Vibrio aestuarianus infection parameters in the Pacific oyster, Crassostrea gigas
Veterinary Research volume 48, Article number: 32 (2017)
This study investigated oyster infection dynamics by different strains of Vibrio aestuarianus isolated before and after the apparent re-emergence of this pathogen observed in France in 2011. We conducted experiments to compare minimal infective dose, lethal dose 50 and bacterial shedding for six V. aestuarianus strains. Whatever the strain used, mortality was induced in juvenile oysters by intramuscular injection and reached 90–100% of mortality within 5 days. Moreover, bacterial shedding was comparable among strains and reached its maximum after 20 h (≈10 EXP5 bacteria/mL/animal). Similarly, our first estimations of lethal dose 50 were comparable among strains (minimal infective dose around 0.4 × 10EXP5 bacteria/mL and LD50 around 10EXP5 bacteria/mL) by using seawater containing freshly shed bacteria. These results indicate that, at least with these criteria, despite V. aestuarianus strains genetic diversity, the disease process is similar. The strains isolated after the apparent re-emergence of the bacteria in 2011, do not present a more acute virulence phenotype than the reference strains isolated between 2002 and 2007. Finally, our study provides original and noteworthy data indicating that infected oysters shed bacteria at a level above the threshold of LD50 a few days before they die, meaning that infection is expected to spread in a susceptible population.
Vibrio aestuarianus is a gamma proteobacterium causing oyster disease in France since 2001 [1,2,3]. Since 2011, the recent increase in adult oyster mortalities points again to this pathogen as a major concern for aquaculture. This bacterium has thus far been isolated in France, Ireland and Scotland [1, 4, 5] in association with chronic mortalities, and without any reported mortalities in Spain and Italy [6,7,8]. As other vibrios, V. aestuarianus can colonize different niches and has been isolated episodically from seawater, plankton, sediment and regularly from diseased animals (oysters and fish) [3, 7, 9,10,11].
Different strains isolated from oysters in the years 2000, all present different virulence degrees (i.e. inducing different levels of oyster mortalities after intramuscular injection) [1, 3]. Genome-based analyses and phylogenetic studies revealed the existence of two clades being equivalent in terms of virulence and of recent/ancient strain distribution. The ecological significance of these two subclasses remains therefore still unknown .
In term of pathology, studies with reference strains (01/032 and 02/041) demonstrated that after injection, V. aestuarianus can be found in the oyster hemolymph, where it inhibits hemocyte adhesion and phagocytosis capacity, and proliferates abundantly [13, 14]. Some virulence factors were identified like the metalloprotease Vam or one regulating gene (varS) [12, 15].
In a more physiological setting, the bacteria can also be transmitted by horizontal waterborne transmission: in cohabitation experiments  or in cohabitation experiments coupling V. aestuarianus with another recognized oyster pathogen, Vibrio tasmaniensis . To render detection and quantification easier, green fluorescent protein (GFP)-tagging of strains can be used ; an approach also used in the current study. All these studies demonstrated that in lab experiments, the bacteria can pass from one animal to another through the seawater.
Even if V. aestuarianus’ ecology and virulence mechanisms are more and more studied, little is known about the infection processes and propagation dynamics inside an oyster population. Many infection parameters such as the minimum infective dose or the bacterial shedding during the pathogenesis are still unknown. In this publication, we developed new experimental protocols to estimate these parameters to better understand V. aestuarianus infection dynamics. Moreover, different strains, isolated before or after the recent re-emergence of the bacteria, will be compared with regard to these characteristics.
Materials and methods
Bacteria: growth conditions, detection and quantification
Six V. aestuarianus strains were used in this study and are presented in Table 1. Bacteria were grown in Zobell Broth [peptone 4 g/L, yeast extract 1 g/L, Tris buffer 0.5 g/L adjusted to pH 7.4 in artificial sterile seawater (ASW), supplemented with kanamycine 100 µg/mL for the GFP-tagged strain] and stock cultures were stored at −80 °C in Zobell containing 15% glycerol (v/v). For injection procedures, bacteria were grown for 24 h at 22 °C before adjustment to concentrations ranging from 5 × 102 to 5 × 108 bacteria/mL in ASW. Bacteria purity and concentration were checked by plating on Zobell agar.
Vibrio aestuarianus DNA quantities in oyster tissues or seawater were estimated by qPCR  after DNA extraction following QiaAmp® tissue kit procedures (Qiagen®) and dilutions for oyster tissue extracts to adjust total DNA concentration to 5 ng/µL. A standard curve was established applying “diluted genomes”.
Briefly, the standard was prepared using the relation between the concentration of DNA in the V. aestuarianus 02/041 and the theoretical number of genomes, calculated on the basis of the DNA mass divided by the genomic molecular weight for V. aestuarianus (2.77 × 109 g/mol, based on a genome size of 4.20 Mbp for V. aestuarianus ). Assays were performed on MX3000P and MX3005P machines (Agilent®) with the Brillant III Ultrafast kit (Stratagene®) following the manufacturer’s instruction. Bacterial concentrations were also estimated by Flow Cytometry (Coulter Epics XL cytometer, Beckman®) on 10 000 events or after 5 min with a threshold fixed on FL1 fluorescence.
Specific pathogen-free oysters
Batches of Pacific oyster Crassostrea gigas were produced in March and April 2013 at the Ifremer hatcheries in Argenton, France and La Tremblade, France, and in April 2015 in La Tremblade. Oysters were kept in experimental facilities from spawning to the experiments described below with UV-treated and filtered seawater and under biosecurity conditions to avoid contamination with major pathogens inducing oyster mortalities: the Ostreid herpesvirus (OsHV-1) and V. aestuarianus. Twelve oysters were screened for the detection of these pathogens by standard protocols [18, 19]. Briefly, after hemolymph sampling in the adductor muscle sinus with a syringe equipped with a needle (0.9 × 25 mm), pieces of 50 mg of mantle and gills were dissected. Dilutions of hemolymph were plated on Zobell agar (10−1, 10−2). DNA from gills and mantle was extracted using a QiAmp® kit. Presence of OsHV-1 and V. aestuarianus DNA was detected by qPCR as described [18, 19].
Bacterial shedding experiments (Additional file 1)
Experiments were performed under static (closed circuit) conditions in aerated seawater maintained at 22 °C during all experiments. Oysters (mean individual weight 12.1 and 13.2 g) were anaesthetized with MgCl2 at a concentration of 50 g/L in tap water. Each oyster was intramuscularly injected with 50–100 µL of a V. aestuarianus suspension and placed into 0.5 L of UV-treated seawater. In a first part, we tested the 02/041-GFP strain at different doses, in two experiments. A total of sixty oysters were placed individually in a beaker (ten oysters for each of the four tested injected doses: 5 × 106, 5 × 107 (tested twice) 1 × 108 and 5 × 108 bacteria/animal). In a second part, the six strains were compared. Three groups containing each 10 animals were infected together with 5 × 108 bacteria/animal in a single tank. Water was daily sampled and bacterial concentrations were estimated by flow cytometry and qPCR as described above. Estimated shedding rates were expressed as Bacteria/mL/oyster/day.
Minimum infectious dose experiments (Additional file 1)
Experiments were performed under static conditions in aerated seawater maintained at 20 °C during all tests. Contaminated seawater was produced by placing 20 injected oysters in 10 L of UV-treated, filtered seawater (intramuscular (IM) injection with 5 × 107 bacteria/animal) for 18 h. Bacterial concentration was checked by flow cytometry for GFP-tagged bacteria and qPCR.
In a first experiment, groups of 30 oysters were immersed in contaminated seawaters in 3 L tanks containing the different strains (six strains) at 5 × 107 bacteria/animal for 24 h before seawater renewal. In a second experiment, oysters were individually exposed in 300 mL beakers to six different dilutions of contaminated seawater produced with 02/041 strain. After 24 h of contact, contaminated seawaters were replaced by fresh UV-treated seawater. Finally, in a third experiment, oysters were individually exposed for 24 h to contaminated seawater containing the different strains (six strains) at different doses (three doses). Control seawater corresponds to seawater collected from tanks with artificial sterile seawater (ASW) injected-oysters. Oysters were monitored daily and dead or moribund animals were removed and frozen for subsequent analysis for the duration of the experiment (15 days). Survivors were sacrificed at the end of the experiment. Individual mantle and gill samples, or whole animals in case of survivors, were tested for the presence of V. aestuarianus DNA.
Differences in cumulated mortalities were compared by Chi squared analysis. Survival data were analyzed using Kaplan–Meier survivor functions and compared using the log-rank test. Kruskal–Wallis tests were applied to assess significant differences between the shedding of the different strains, as a normal distribution was not assumed on log-transformed bacterial concentrations (Shapiro–Wilk test). For all tests, the significance threshold was p < 0.05. All these statistical analyses were gathered using biostaTGV . Finally, the LD50 was estimated from dose effect curves by non-linear regression curve fitting using GraphPad Prism software (San Diego, CA, USA) when enough data were available. For comparison of strains, doses bracketing the LD50 (i.e. inducing more or less than 50% mortalities) were used.
Bacterial shedding experiments
To determine the optimal dose to inject, and the appropriate time to measure shedding, an individual bacterial-shedding protocol was developed first on the V. aestuarianus reference strain 02/041 and its GFP counterpart. Daily individual bacterial shedding, corresponding to more than 103 bacteria/mL/day, was first detected by qPCR and flow cytometry at 1 h post-challenge for 5 × 108 injected bacteria, after 22 h for 5 × 107 or 1 × 108 injected bacteria, and after 30 h for 5 × 106 injected bacteria (Figure 1A). Bacterial concentration reached its maximum of around 105 bacteria/mL at 22 h post-infection with the 5 × 108 bacteria injection, and of around 48 h for the 5 × 106 and 5 × 107 bacteria injected trials (Figure 1A). Cumulated mortality in intramuscularly injected oysters reached 90% for the 10-day experiment whatever the dose we used (Figure 1B). Neither mortality nor any V. aestuarianus DNA were observed in the control tanks.
To evaluate the total shedding of the different V. aestuarianus strains, on a group of oysters, total DNA in the seawater was estimated by qPCR on samples taken between 19 and 22 h post-intramuscular injection of fresh concentrated bacterial suspensions (OD600nm = 1) in three independent experiments. Between 3.7 × 105 and 9.4 × 105 bacteria/mL/animal were detected into the surrounding seawater, even for the moderately virulent strain (Figure 2). No statistically significant differences could be detected between strains (p = 0.116, Kruskal–Wallis test) nor between experiments (p = 0.412). Finally, for the GFP-tagged strain, quantification by flow cytometry (mean 2.3 × 105 bacteria/mL; sd 6 × 104) was considered as not significantly different from estimation obtained by QPCR (Figure 2; p = 0.324).
Minimum infectious dose experiments
To assess whether these shed V. aestuarianus can infect (enter into the host’s tissues) and to determine a minimal infective dose, sentinel oysters were placed into the contaminated seawater (undiluted or diluted). First mortalities were observed 4 days post infection by immersion into undiluted contaminated seawater, and recorded until day 13 (minimal average survival 23%, Figure 3). All the highly virulent strains tested (02/041, 02/092, 12/016, 12/063) induced comparable mortality kinetics, as revealed by Kaplan–Meier analyses (data not shown). It is important to notice that the moderately virulent strain 07/115 did not induce any mortality in sentinel oysters with similar amounts of bacteria. Finally, in control tanks, no mortality was noticed (Figure 3).
The average cumulated mortality at different contaminated seawater dilutions (for the reference strain 02/041) is displayed in Table 2. At 7.9 × 105 bacteria/mL, mortality reached 70%, whilst at 0.5 × 105 bacteria/mL, only 30% of mortality was observed. Mortality was not evidenced after immersion with contaminated seawater containing 3 × 104 bacteria/mL or less. qPCR analyses of sampled moribunds indicated that all mortalities at all doses were linked to very large amounts of V. aestuarianus (more than 107 bacteria/25 ng of total DNA).
A lethal dose 50 (LD50), i.e. a dose inducing 50% mortality at the end of the experiment, can be estimated at 1.3 × 105 bacteria/mL [i.e. 5.11 Log(bacteria/mL)] on this oyster batch, after an initial 24 h contamination by immersion in undiluted contaminated seawater at 20 °C (Table 2). Twelve surviving individuals (sampled at day 15, on the 60 initially infected animals) were crushed in their totality before analyses of V. aestuarianus content. In none of them bacterial DNA could be amplified by qPCR even if we cannot exclude the presence of small amounts of DNA with the actual detection limit of our diagnostic tool (1.6 × 102 cells/mL ).
Lethal dose 50 was also estimated for the other strains to compare their virulence, on a second oyster batch by exposing the oysters to different doses of shed bacteria in individual beakers. Doses inducing 50% of mortality for the different strains were all estimated within 105 and 106 B/mL (Table 3). Interestingly, on this second oyster batch, LD50 for the 02/041 strain could be estimated between 5.8 × 105 and 1.7 × 106 bacteria/mL, which is higher than our first estimation (LD50 estimated at 1.3 × 105 bacteria/mL on the first oyster batch), underlining the highly variable oyster physiology.
This study provides first insights into V. aestuarianus infection dynamics by conducting experimental infections to quantify bacterial shedding from infected oysters over time and to determine a minimal infective dose and an LD50. Moreover, the different strains were compared for properties other than and complementary to the classically “rate of mortality after intramuscular injection” .
To investigate bacterial shedding from oysters, animals were intramuscularly injected with different doses of bacteria, to ensure that the animals were synchronously infected with a standardized amount of bacteria. Bacteria released into the surrounding seawater were quantified by qPCR and flow cytometry using a GFP-tagged strain, previously demonstrated as comparable to the wild-type strain in terms of induced mortality. Even if GFP-tagged bacteria allow a real-time monitoring of bacteria in suspension, such tools present a moderate sensitivity, previously estimated for this strain around 103 cells/mL . On the other side, classical qPCR allows the detection of as little as 102 cells/mL  but does not distinguish dead bacteria from living ones. By combining these tools, a quick shedding was observed leading to detection, as soon as 1 h post infection of bacteria reaching 103 to 105 cells/mL/animal depending on the injected dose.
Progressive accumulation of bacteria was observed in each tank, reaching a plateau after 24 h for the highest dose and 50 h for the lowest one. It is noticeable that animal death was not observed until 50 h, which corresponds to the time limit of detection. These results are consistent with other models, in which moribund animals are well-known as important shedders, via thus far still unknown mechanisms. For instance, in the Aeromonas salmonicida–Salmo salar model, release of bacteria from morbid animals was estimated in the order of 105 to 108 cfu/fish/h . For the bacteria Vibrio harveyi infecting the abalone Haliotis tuberculata, bacterial shedding was estimated around 104 bacteria/abalone/mL .
Even if V. aestuarianus strains can present genetic diversity, our results suggest that the disease process is similar: comparison of the release of and the impact of different strains isolated in 2002 and 2012, and belonging to clade A or B  did not show noticeable difference. Similar shedding characteristics were observed in the different strains. No remarkable difference of bacterial shedding for the strains from clade A (12/016 or 02/041) or clade B (12/063, 02/092), and no changes in induced mortalities of sentinel oysters could be detected. In all moribund oysters, large amounts of V. aestuarianus were observed after hemolymph plating (more than 107 bacteria/mL), confirming the colonization and multiplication of the pathogen inside the animal.
Cohabitation protocols and immersion protocols in the presence of sediment were already described for this bacterium [11, 17]. However, in our experiments, cohabitation and contamination with cultured bacteria appeared less reproducible (Travers, pers. comm.) than experimental infections with oyster-shedded bacteria, as if the passage through the host homogenized or induced bacterial infectivity. Similarly, studies of the interaction of Vibrio vulnificus with eels suggest that host cell contact is required for its pathogenicity .
This protocol was chosen to estimate bacterial minimal infective doses and LD50s as it most closely mimics natural exposure to a pathogen . Infections, duplicated in time, with different doses of shedded bacteria were performed either on ten separated individuals (10 tanks) or on thirty animals in triplicates (three tanks). With 5 to 8 × 105 bacteria/mL, cumulated mortalities reached in each case 77% in 15 days. However, to limit bacterial exposure to the first 24 h and to avoid potential transmission between animals in a same tank, final LD50 and minimal infective doses were estimated on animals physically separated in ten 0.5 L-tanks. The minimum infective dose required to reliably induce infection after a 24 h immersion period in contaminated seawater, was estimated at 0.4 × 105 bacteria/mL and the LD50 around 105 bacteria/mL. Comparison of the doses inducing 50% of mortality on two oyster batches revealed some differences (for the 02/041 strain) even if oysters were comparable in term of age and size. Genetic background, as well as life history traits can influence oysters sensitivity to pathogens (e.g. effective infectious dose, and survival [16, 26, 27]). This sensitivity may also be linked to other transmission parameters (e.g. shedding). In absence of standardized oyster lineages, we should thus favor (1) experiments in which all epidemiological parameters are recorded in parallel on the same animals and (2) experiments that are repeated on different oyster batches.
Interestingly, taken together, our results indicate that one contaminated oyster placed into 350 mL of seawater can release 5 to 10 × 105 bacteria/mL in 24 h, and the LD50 was estimated at 1 × 105 bacteria/mL. These findings are very significant for the dynamic of the disease because they indicate that shedding begins at a level already above the LD50 before mortalities occur, meaning that an infected oyster can pass the infection to at least one other oyster, clearly favoring disease-spread in a susceptible population. Additionally, by intramuscular injection with the same bacterial isolate (02/041), as little as 100 bacteria/animal can induce more than 80% mortalities . These data highlight the importance of the initial step in the infection process. Moreover, analyses of surviving individuals revealed the absence of bacteria, which might suggest that these animals were not infected during the 24 h-bath or cleared the infection. This observation may be linked to genetic/physiological specificities of these animals. Even if the heritability for survival of C. gigas, when exposed to V. aestuarianus is low to moderate , oysters selected for their higher resistance to V. aestuarianus infection could constitute a future line of research. The basis of the observed resistance may rely on mechanisms developed by the oysters to prevent the bacteria to enter and/or to multiply. However, more sensitive tools and more targeted screening of tissue are needed to confirm this hypothesis. Future efforts on the comprehension of this crucial initial step are thus necessary. First studies suggested that V. aestuarianus could be found after a few hours in the hemolymph and mantle during cohabitation challenges [17, 21]. However the entry site, the targeted tissues, and the timeline are still unknown.
Vibrio aestuarianus cells are difficult to find and culture from environmental samples. Moreover, only little field data on V. aestuarianus concentrations in oyster environments during epidemics are available. Recent intensive field surveys allowed its isolation from oysters, mussels, plankton, sediments and seawater in France, Spain and Italy [6, 7, 11]. V. aestuarianus can reach 103 to 104 cell/g sediment in warm months [7, 11] and 102 cell/mL in the seawater column in the Adriatic sea. Interestingly, V. aestuarianus can be found associated with plankton where up to 106 bacteria/g were quantified . However, detection protocols  did not allow the discrimination of virulent and non-virulent strains, and thus the importance of the plankton compartment in the effective concentration of virulent V. aestuarianus, and/or its transmission to oysters is still unknown.
Finally, our study demonstrates that virulence classification determined only through injection protocols with high doses of bacteria can be source of debates, leading some authors to consider some strains as pathogens . The V. aestuarianus 07/115 strain, induces high levels of mortality when injected at 5 × 108 bacteria/animal, but does not affect oysters when injected at very low doses (102 bacteria/animal ) or when present in high concentrations in the surrounding water. Future efforts on animal models and infection protocols are certainly needed to clearly define mollusk pathogens.
In conclusion, this study provides new experimentally acquired data on the V. aestuarianus–C. gigas interaction by estimating bacterial shedding and bacterial infective doses. However, more integrative population-based studies are now needed to try to link these first parameter estimations to natural occurring epidemics.
Garnier M, Labreuche Y, Garcia C, Robert A, Nicolas JL (2007) Evidence for the involvement of pathogenic bacteria in summer mortalities of the Pacific oyster Crassostrea gigas. Microb Ecol 53:187–196
Garnier M, Labreuche Y, Nicolas JL (2008) Molecular and phenotypic characterization of Vibrio aestuarianus subsp. francensis subsp. nov., a pathogen of the oyster Crassostrea gigas. Syst Appl Microbiol 31:358–365
Saulnier D, De Decker S, Haffner P, Cobret L, Robert M, Garcia C (2010) A large-scale epidemiological study to identify bacteria pathogenic to Pacific Oyster Crassostrea gigas and correlation between virulence and metalloprotease-like activity. Microb Ecol 59:787–798
EFSA (2015) Scientific opinion of the panel on animal health and welfare on a request from the European Commission on oyster mortality. EFSA J 13:4122
McCleary S, Henshilwood K (2015) Novel quantitative TaqMan® MGB real-time PCR for sensitive detection of Vibrio aestuarianus in Crassostrea gigas. Dis Aquat Org 114:239–248
Romero A, Costa MD, Forn-Cuni G, Balseiro P, Chamorro R, Dios S, Figueras A, Novoa B (2014) Occurrence, seasonality and infectivity of Vibrio strains in natural populations of mussels Mytilus galloprovincialis. Dis Aquat Org 108:149–163
Vezzulli L, Pezzati E, Stauder M, Stagnaro L, Venier P, Pruzzo C (2014) Aquatic ecology of the oyster pathogens Vibrio splendidus and Vibrio aestuarianus. Environ Microbiol 17:1065–1080
Domeneghetti S, Varotto L, Civettini M, Rosani U, Stauder M, Pretto T, Pezzati E, Arcangeli G, Turolla E, Pallavicini A, Venier P (2014) Mortality occurrence and pathogen detection in Crassostrea gigas and Mytilus galloprovincialis close-growing in shallow waters (Goro lagoon, Italy). Fish Shellfish Immunol 41:37–44
Montes M, Farto R, Pérez MJ, Nieto TP, Larsen JL, Christensen H (2003) Characterization of Vibrio strains isolated from turbot (Scophthalmus maximus) culture by phenotypic analysis, ribotyping and 16S rRNA gene sequence comparison. J Appl Microbiol 95:693–703
Zhang XJ, Qin GM, Bing XW, Yan BL, Liang LG (2011) Molecular and phenotypic characterization of Vibrio aestuarianus, a pathogen of the cultured tongue sole, Cynoglossus semilaevis Gunther. J Fish Dis 34:57–64
Azandégbé A, Garnier M, Andrieux-Loyer F, Kérouel R, Philippon X, Nicolas JL (2010) Occurrence and seasonality of Vibrio aestuarianus in sediment and Crassostrea gigas haemolymph at two oyster farms in France. Dis Aquat Org 91:213–221
Goudenège D, Travers MA, Lemire A, Petton B, Haffner P, Labreuche Y, Tourbiez D, Mangenot S, Calteau A, Mazel D, Nicolas JL, Jacq A, Leroux F (2015) A single regulatory gene is sufficient to alter Vibrio aestuarianus pathogenicity in oysters. Environ Microbiol 17:4189–4199
Labreuche Y, Lambert C, Soudant P, Boulo V, Huvet A, Nicolas JL (2006) Cellular and molecular hemocyte responses of the Pacific oyster, Crassostrea gigas, following bacterial infection with Vibrio aestuarianus strain 01/32. Microbes Infect 8:2715–2724
Labreuche Y, Soudant P, Gonçalves M, Lambert C, Nicolas JL (2006) Effects of extracellular products from the pathogenic Vibrio aestuarianus strain 01/32 on lethality and cellular immune responses of the oyster Crassostrea gigas. Dev Comp Immunol 30:367–379
Labreuche Y, Le Roux F, Henry J, Zatylny C, Huvet A, Lambert C, Soudant P, Mazel D, Nicolas JL (2010) Vibrio aestuarianus zinc metalloprotease causes lethality in the Pacific oyster Crassostrea gigas and impairs the host cellular immune defenses. Fish Shellfish Immunol 29:753–758
Azéma P, Travers MA, De Lorgeril J, Tourbiez D, Degremont L (2015) Can selection for resistance to OsHV-1 infection modify susceptibility to Vibrio aestuarianus infection in Crassostrea gigas? First insights from experimental challenges using primary and successive exposures. Vet Res 46:139
De Decker S, Saulnier D (2011) Vibriosis induced by experimental cohabitation in Crassostrea gigas: evidence of early infection and down-expression of immune-related genes. Fish Shellfish Immunol 30:691–699
Pepin JF, Riou A, Renault T (2008) Rapid and sensitive detection of Ostreid Herpesvirus1 in oyster samples by real-time PCR. J Virol Methods 149:269–276
Saulnier D, De Decker S, Haffner P (2009) Real-time PCR assay for rapid detection and quantification of Vibrio aestuarianus in oyster and seawater: a useful tool for epidemiologic studies. J Microbiol Methods 77:191–197
The biostaTGV, the biostatistic webpage [on line] https://marne.u707.jussieu.fr/biostatgv/?module=tests
Aboubaker MH, Sabrié J, Huet M, Koken M (2013) Establishment of stable GFP-tagged Vibrio aestuarianus strains for the analysis of bacterial infection-dynamics in the Pacific oyster, Crassostrea gigas. Vet Microbiol 164:392–398
Rose AS, Ellis AE, Munro ALS (1989) The infectivity by different routes of exposure and shedding rates of Aeromonas-Salmonicida subsp. Salmonicida in Atlantic Salmon, Salmo-Salar L. Held in seawater. J Fish Dis 12:573–578
Travers MA, Barbou A, Le Goïc N, Huchette S, Paillard C, Koken M (2008) Construction of a stable GFP-tagged Vibrio harveyi strain for bacterial dynamics analysis of abalone infection. FEMS Microbiol Lett 289:34–40
Jones MK, Oliver JD (2009) Vibrio vulnificus: disease and pathogenesis. Infect Immun 77:1723–1733
Nordmo R (1997) Strengths and weaknesses of different challenge methods. Dev Biol Stand 90:303–309
Dégremont L, Lamy JB, Pépin JF, Travers MA, Renault T (2015) New insight for the genetic evaluation of resistance to Ostreid Herpesvirus infection, a worldwide disease, in Crassostrea gigas. PLoS One 10:e0127917
Dégremont L, Garcia C, Allen SK Jr (2015) Genetic improvement for disease resistance in oysters: a review. J Invertebr Pathol 131:226–241
Azéma P, Lamy JB, Boudry P, Renault T, Travers MA, Dégremont L (2017) Genetic parameters of resistance to Vibrio aestuarianus, and OsHV-1 infections in the Pacific oyster, Crassostrea gigas, at three different life stages. Genet Sel Evol 49:23
Madec S, Pichereau V, Jacq A, Paillard M, Boisset C, Guérard F, Paillard C, Nicolas JL (2014) Characterization of the secretomes of two vibrios pathogenic to mollusks. PLoS One 9:e113097
The authors declare that they have no competing interests.
Conception and design: MAT, CL, DT; Acquisition of data: MAT, DT, LP, PH, AKD, MA, LD, MK, or analysis and interpretation of data: MAT, DT, LP, PH, AKD, MK, Manuscript: MAT, MK, LD, CL. All authors read and approved the final manuscript.
Firstly, we acknowledge the anonymous reviewers for their careful reading of our manuscript and constructive comments. We wish to acknowledge Bruno Petton (IFREMER, Lemar) for SPF oyster production. Moreover, the oysters used in this work were produced and maintained in controlled conditions at the IFREMER hatchery in La Tremblade and at the IFREMER nursery in Bouin. We are very grateful to the hatchery and nursery teams for their assistance in oyster production.
This study was supported by the GIGASSAT project funded by ANR-AGROBIOSPHERE (ANR-12-AGRO-0001-01) and by the French Ministries of Ecology and Agriculture through the research program “AESTU” (Convention DPMA 2014-Ifremer).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Travers, M., Tourbiez, D., Parizadeh, L. et al. Several strains, one disease: experimental investigation of Vibrio aestuarianus infection parameters in the Pacific oyster, Crassostrea gigas . Vet Res 48, 32 (2017) doi:10.1186/s13567-017-0438-1